HOW WE HELP
NET Cancer is the FASTEST growing class of CANCER worldwide
HELP US HELP OTHERSNEUROENDOCRINE TUMOURS (NETs) OVERVIEW
-
Neuroendocrine tumours (NETs) are abnormal growth of cells (neoplasms) that arise from cells of the diffuse neuroendocrine system.
-
NETs are considered complex tumours because both tumor growth and hormonal function must be addressed.
-
NETs are most common in the lung or gastrointestinal system, but they can also originate in other parts of the body such as the thyroid, thymus, pancreas, adrenals, paraganglia, ovaries and testes.
-
NETs are classified as functional (produce hormones that cause symptoms), or non-functional (may or may not produce hormones and do not cause hormonal symptoms).
-
The cause of NETs is currently unknown.
CNETS NEWS
CNETS Board Member Awareness
CNETS Board Member Awareness Patient Education and Fundraising A core function of CNETS is to offer the Canadian neuroendocrine cancer community useful, impactful and informative educational resources [...]
QEII Times & Chronicle Herald Publishes Articles on NET Cancer & Ga68-Dotatate
CNETS participates in and supports QEII fall publication on Ga68/NETSPOT accessibility in Atlantic Canada. The QEII Times and the Chronicle Herald published a two-page spread on Saturday, October 16, 2021. [...]
Les Cancers Endocriniens, published in Le Médecin du Québec
Les Cancers Endocriniens, published in Le Médecin du Québec, October 2021 Dre. Cynthia Landry is a primary care physician in Châteauguay, Quebec, working as an emergency physician at the Anna-Laberge hospital. Dre. [...]
From Gallstones to Cancer: A Mother’s Journey with NETs
Our amazing Hamilton/Halton/Niagara NET Support Group Leader, Vannesa Mann, shares her inspirational story! Zoomer | September 10th, 2021 For people with neuroendocrine tumours, early diagnosis and timely access to approved treatments can [...]
Pewter Zebra Keyfobs/Pendants
Volunteers create one-of-a-kind handmade Pewter Zebra Keyfobs/Pendants to help raise awareness & funds for CNETS Al Gillis is a neuroendocrine cancer patient and member of the Toronto Patient and Caregiver support group. One of [...]
Temozolomide Access in Ontario
CNETS is pleased to share the news that the oral chemotherapy drug, temozolomide, often used in combination with capecitabine, known as the CAPTEM regimen, is now more accessible to Ontario-based neuroendocrine tumour (NET) patients. [...]
CNETS PRIORITIES
SUPPORT
- In-person peer-led support groups meetings
- Dedicated patient email and phone support
- Online private support groups for patients & caregivers
EDUCATION
- Patient and caregiver education sessions across Canada
- Robust online patient educational resources
- Printed educational resources including the NET Reference Guide
- Annual NET Medical and Scientific Meeting
AWARENESS
- Raise awareness of NET cancer to the general public & the medical community
- Participate in World NET Cancer Day Activities
